Sermorelin vs HGH: How They Differ

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This guide is part of the PlexusDx Education Hub, where we translate GLP-1 therapies, longevity peptides, and metabolic science into decisions you can actually use. Explore the full Peptides & GLP-1 library.

Sermorelin and HGH get lumped together, but they are not the same thing, and the difference is the most useful thing to understand about sermorelin. One asks the body to release its own growth hormone; the other supplies growth hormone from outside. This page draws that line clearly, then covers the molecule, its status, and the genetics beneath it.

Sermorelin is not human growth hormone

HGH refers to growth hormone itself. Sermorelin is different: it is a releasing-hormone analog that signals the body to make and release its own growth hormone. That distinction matters because the two work through different mechanisms, even though both touch the same growth hormone axis. Confusing them leads to wrong assumptions about how sermorelin behaves.

How sermorelin prompts your own growth hormone

Sermorelin acts on the pituitary to trigger growth hormone release in a pulsatile, physiological pattern, mirroring the way the body normally signals. Because it encourages an endogenous process rather than replacing it, the mechanism is often described as physiological. The downstream biology runs through the growth hormone axis and IGF-1 signaling, both well characterized in peer-reviewed literature.

The molecule and its history

Sermorelin is a synthetic 29-amino-acid peptide reproducing the active portion of human growth hormone-releasing hormone, GHRH 1-29. It was FDA-approved in 1990 for diagnostic use and pediatric growth hormone deficiency, and the branded product was discontinued in 2008. Today most adults access it as a compounded preparation from a licensed 503A pharmacy.

Safety and compounding notes

Sermorelin has a documented safety profile in the clinical literature, with common side effects, warnings, and contraindications that vary by preparation. Because compounded products depend on the pharmacy, confirm state licensure and adherence to USP standards for sterility and potency, and review your medical history with a prescribing provider before beginning.

The genetic terrain beneath the axis

Whether you are considering sermorelin or thinking about growth hormone biology generally, your own genes shape the terrain. Variants in FOXO3, IGF1, and KLOTHO influence the growth hormone and IGF-1 signaling that sermorelin works through. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across that landscape. It never predicts response to any compound; it maps the baseline. PlexusDx offers sermorelin through its Longevity Protocols, detailed on the Sermorelin product page.

Why the difference matters when comparing options

Once you see that sermorelin prompts your own growth hormone while HGH supplies it directly, the comparison stops being apples-to-apples. The two differ in mechanism, and they differ in how they are accessed and overseen. Sermorelin is accessed as a compounded preparation from a licensed 503A pharmacy under a prescription, which is a different framework than an approved brand product.

For anyone weighing options, that means the useful question is not which is "stronger" in the abstract but which fits a given person, and that is a judgment for a prescribing provider. Neither is a shortcut, and both touch the same growth hormone axis from different directions. Verifying licensure, clinical oversight, and USP adherence matters regardless of which direction a conversation eventually takes, because safe sourcing applies either way.

Framed correctly, the sermorelin-versus-HGH question becomes less about hype and more about mechanism, oversight, and fit. One prompts your own biology; the other supplies a hormone from outside. Understanding that distinction helps you ask better questions of a prescriber and steer clear of sources that blur the two to make a sale. The comparison is a starting point for that conversation, never a substitute for it. Approach it as ordinary due diligence, and the right choice, if there is one, becomes far easier to reach alongside a provider.

Frequently Asked Questions

Is sermorelin the same as HGH?

No. HGH is growth hormone itself, supplied from outside the body. Sermorelin is a releasing-hormone analog that signals your own pituitary to make and release growth hormone. They work through different mechanisms even though both involve the growth hormone axis, so they should not be treated as interchangeable.

Why is sermorelin described as physiological?

Because it prompts growth hormone release in a pulsatile pattern that mirrors the body's natural rhythm rather than supplying a constant external hormone. It encourages an endogenous process, and its downstream effects run through the growth hormone axis and IGF-1 signaling documented in peer-reviewed clinical literature.

What is sermorelin, exactly?

Sermorelin is a synthetic 29-amino-acid peptide mirroring GHRH 1-29. Approved by the FDA in 1990 for diagnostic and pediatric use and discontinued as a brand in 2008, it is now accessed mainly as a compounded preparation from a licensed 503A pharmacy for adults.

Does genetics tell me how I will respond?

No. The Precision Peptide Genetic Test does not predict response to sermorelin or growth hormone biology. It reads pathway variants in FOXO3, IGF1, and KLOTHO that describe your baseline, offering upstream context for an informed conversation with a prescribing provider rather than a prediction.

Keep reading across the PlexusDx Education Hub for more on peptides, metabolism, and the genetics beneath them. Return to the Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.